Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 6, 1998, Pages 437-447

  Kruczynski, Anna ^a   Colpaert, Francis ^a   Tarayre, Jean Pierre ^a   Mouillard, Pierre ^a   Fahy, Jacques ^a   Hill, Bridget T ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Cancer chemotherapy; Human tumor xenografts; Murine tumors; Vinflunine

Indexed keywords

NAVELBINE; UNCLASSIFIED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE; VINFLUNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA P 388; LIFESPAN; LUNG CANCER; MELANOMA B16; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HUMANS; LEUKEMIA P388; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SURVIVAL ANALYSIS; SURVIVAL RATE; VINBLASTINE;

EID: 0031912695     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050764     Document Type: Article

References (37)

1. Ashizawa T, Asada M, Kobayashi E, Okabe M, Gomi K, Hirata T (1993) Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukaemia and human lung carcinoma xenografts in mice. Anti-cancer Drugs 4: 577
2. Barnett CJ, Cullinan GJ, Gerzon K, Hoying RC, Jones WE, Newlon WM, Poore GA, Robinson RL, Sweeney MJ, Todd GC, Dyke RW, Nelson RL (1978) Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate. J Med Chem 21: 88
3. Berrier C, Jacquesy JC, Jouannetaud MP, Renoux A (1987) Hydroxylation and bromination of indolines and tetrahydroquinolines in superacids. New J Chem 11: 605
4. Bissery MC, Guéritte D, Guéritte-Voegelein F, Lavelle F (1991) Experimental antitumour activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51: 4845
5. Blasko G, Cordell GA (1990) Isolation, structure elucidation, and biosynthesis of the bisindole alkaloids of Catharanthus. In: Brossi A, Suffness M (eds) The alkaloids - antitumor bisindole alkaloids from Catharanthus roseux (L.). Academic Press, San Diego, p 1
6. Boven E, Winograd B (eds) (1991) The nude mouse in oncology research. CRC, Boca Raton, Florida
7. Cersosimo RJ, Bromer R, Licciardello JTW, Ki Hong W (1983) Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new Vinca alkaloid. Pharmacotherapy 3: 259
8. Cros S, Wright M, Morimoto M, Lataste H, Couzinier JP, Krokorian A (1989) Experimental antitumour activity of navelbine. Semin Oncol 16: 15
9. Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute (1984) In vivo cancer models 1976-1982. NIH Publication 84-2635. United States Government Printing Office, Washington, D.C.
10. Donehower RC, Rowinsky EK (1993) Anticancer drugs derived from plants. In: De Vita VT, Hellman S, Rosenberg SA (eds) cancer principles & practice of oncology. Lippincott, Philadelphia, p 409
11. Dykes D, Bissery MC, Harrisson SD, Waud WR (1995) Response of human tumour xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere). Invest New Drugs 13: 1
12. Fahy J, Duflos A, Jacquesy JC, Zunmo F, Kruczynski A, Etiévant C, Barret JM, Hill BT (1997) A new family of Vincaalkaloids with promising antitumour properties. Proc Am Assoc Cancer Res 38: 226
13. Fiebig HH, Berger DP, Dengler WA, Wallbrecher E, Winterhalter BR (1992) Combined in vitro/in vivo test procedure with human tumour xenografts for new drug development. In: Fiebig HH, Berger DP (eds) Immunodeficient mice in oncology. Karger, Basel, p 321
14. Ga KL, Faulds D (1994) Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs Aging 5: 200
15. Gomi K, Ohno H, Nomura K, Okabe M, Kobayashi K, Niitani H (1992) Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture. Jpn J Cancer Res 83: 532
16. Hendriks HR, Langdon S, Dietmar PB, Breistol HH, Fodstad Ø, Schwartsmann G (1992) Comparative antitumor activity of vinblastine-isoleucinate and related Vinca alkaloids in human tumour xenografts. Eur J Cancer 28A: 767
17. Johnson IS, Wright HF, Svoboda GH (1959) Experimental basis for clinical evaluation of anti-tumor principles derived from Vinca rosea Linn. J Lab Clin Med 54: 830
18. Johnson IS, Amstrong JG, German M, Burnett JP (1963) The Vinca alkaloids: a new class of oncolytic agents. Cancer Res 23: 1390
19. Johnson SA, Harper P, Hortobagyi GN, Pouillart P (1996) Vinorelbine: an overview. Cancer Treat Rev 22: 127
20. Kohl NE, Omer CA, Conner MW, Anthony NJ, Davide JP, De Solms SJ, Giulliani EA, Gomez RP, Graham SL, Hamilton K, Handt LK, Hartman GD, Koblan KS, Kral AM, Miller PJ, Mosser SD, O'Neil TJ, Rands E, Schaber MD, Gibbs JB, Oliff A (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras trangenic mice. Nature Med 1: 792
21. Langdon SP, Hendriks HR, Pratesi G, Berger DP, Fodstad Ø, Fiebig HH, Boven E (1994) Preclinical phase II studies in human tumour xenografts: a European multicenter follow-up study. Ann Oncol 5: 415
22. Langlois N, Guéritte F, Langlois Y, Potier P (1976) Application of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J Am Chem Soc 98: 7017
23. Mangeney P, Andriamialisoa RZ, Lallemand JY, Langlois N, Langlois Y, Potier P (1979) 5′-Nor-anhydrovinblastine, prototype of a new class of vinblastine derivatives. Tetrahedron 35: 2175
24. Mantel N (1963) Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58: 690
25. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719
26. Mosteller F, Royrke R (1973) Sturley statistics: non-parametrics and order statistics. Addison-Wesley, Reading, Massachusetts
27. Nobel RL, Beer CT, Cutts JH (1958) Further biological activities of vincaleukoblastine - an alkaloid isolated from Vinca rosea (L.). Biochem Pharmacol 1: 347
28. Olah GA, Parker DG, Yoneda N (1978) Oxyfuctionalization of hydrocarbons. 9. Superacid-catalyzed oxygenation of alkanes. Angew Chem Int Ed Engl 17: 909
29. Pearce HL (1990) Medicinal chemistry of bisindole alkaloids from Catharanthus. In: Brossi A, Suffness M (eds) The alkaloids - antitumor bisindole alkaloids from Catharanthus roseus (L.). Academic Press, San Diego, p 145
30. Photiou A, Sheikh MN, Bafaloukos D, Tetsas S (1992) Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. J Cancer Res Clin Oncol 118:249
31. Tashiro T, Inaba M, Kobayashi T, Sakurai Y, Maruo K, Onishi Y, Ueyama Y, Nomura T (1989) Responsiveness of human lung cancer/nude mouse to antitumour agents in a model using clinically equivalent doses. Cancer Chemother Pharmacol 24:187
32. Toso T, Lindley C (1995) Vinorelbine: a novel alkaloid. Am J Health Syst Pharm 52:1287
33. Tsuruo T, Inaba T, Yamori T, Ohnishi Y, Ashizawa T, Sakai T, Kobayashi S, Gomi K (1994) Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice. Anticancer Drugs 5:634
34. Van Tellingen O, Sips JHM, Beijnen JH, Bult A, Nooijen WJ (1992) Pharmacology, bio-analysis and pharmacokinetics of the Vinca alkaloids and semi-synthetic derivatives (review). Anticancer Res 12:1699
35. Venditti JM (1975) Relevance of transplantable animal-tumor systems to the selection of new agents for clinical trial. In: Pharmacological basis of cancer chemotherapy. Williams and Wilkins, Baltimore, p 245
36. Venditti JM (1981) Preclinical drug development: rationale and methods. Semin Oncol 8:349
37. Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC, Wallace J, Straughan DW (1988) UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 22:195